In vitro activity of ABT-773, a new ketolide, against recent clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. (Antimicrobial agents and chemotherapy, 2000)

(untitled) - Brueggemann, A; Doern, G; Huynh, H; Wingert, E; Rhomberg, P